JSI RESOURCES: Journal article

Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania’s national HPV vaccine introduction

SHARE THIS

Gavi, the Vaccine Alliance, and global partners were informed by HPV vaccine manufacturers of vaccine supply constraints in 2018. Due to insufficient supply, Gavi-eligible countries, such as Tanzania, needed to determine which age cohorts to vaccinate against HPV based on available vaccine stock. This commentary discusses Tanzania's experience with HPV vaccine introduction and decisions made based on vaccine supply constraints. 

Authors: Anyie J.LiFuraha KyesiWilliam MwengeeAlex MphuruMary Rose GiattasBerrington ShayoRaphael NshunjuDafrossa LyimoAnagha Loharikar

Partner with Us

We strive to build lasting relationships to produce better health outcomes for all.

Menu